These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30626751)

  • 41. Neuronal Aquaporin 1 Inhibits Amyloidogenesis by Suppressing the Interaction Between Beta-Secretase and Amyloid Precursor Protein.
    Park J; Madan M; Chigurupati S; Baek SH; Cho Y; Mughal MR; Yu A; Chan SL; Pattisapu JV; Mattson MP; Jo DG
    J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(1):23-31. PubMed ID: 32154567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Commentary: Abeta N- Terminal Isoforms: Critical contributors in the course of AD pathophysiology.
    Tekirian TL
    J Alzheimers Dis; 2001 Apr; 3(2):241-248. PubMed ID: 12214065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BACE2 expression increases in human neurodegenerative disease.
    Holler CJ; Webb RL; Laux AL; Beckett TL; Niedowicz DM; Ahmed RR; Liu Y; Simmons CR; Dowling AL; Spinelli A; Khurgel M; Estus S; Head E; Hersh LB; Murphy MP
    Am J Pathol; 2012 Jan; 180(1):337-50. PubMed ID: 22074738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids.
    Luo J; Zou H; Guo Y; Huang K; Ngan ES; Li P
    Cell Death Discov; 2022 Feb; 8(1):47. PubMed ID: 35110536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Scapagnini G; D'Agata V
    Cell Biol Toxicol; 2010 Aug; 26(4):367-77. PubMed ID: 20111991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
    Evin G; Sernee MF; Masters CL
    CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation.
    Feng T; Niu M; Ji C; Gao Y; Wen J; Bu G; Xu H; Zhang YW
    Mol Neurobiol; 2016 Aug; 53(6):3690-3701. PubMed ID: 26115702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spatial and temporal control of age-related APP processing in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Lamb BT
    Neurobiol Aging; 2007 Jan; 28(1):75-84. PubMed ID: 16387391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.
    Colombo A; Wang H; Kuhn PH; Page R; Kremmer E; Dempsey PJ; Crawford HC; Lichtenthaler SF
    Neurobiol Dis; 2013 Jan; 49():137-47. PubMed ID: 22940630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
    J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time.
    Luo Y; Bolon B; Damore MA; Fitzpatrick D; Liu H; Zhang J; Yan Q; Vassar R; Citron M
    Neurobiol Dis; 2003 Oct; 14(1):81-8. PubMed ID: 13678669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer's Mouse Model.
    He P; Xin W; Schulz P; Sierks MR
    Mol Neurobiol; 2019 Nov; 56(11):7420-7432. PubMed ID: 31041656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Cell-based β-secretase Enzymatic Assay for Alzheimer's Disease.
    De Araujo Herculano B; Wang Z; Song W
    Curr Alzheimer Res; 2019; 16(2):128-134. PubMed ID: 30543168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
    Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing.
    Wang Y; Cui Y; Liu J; Song Q; Cao M; Hou Y; Zhang X; Wang P
    Alzheimers Res Ther; 2022 Jul; 14(1):103. PubMed ID: 35883144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease.
    Menting KW; Claassen JA
    Front Aging Neurosci; 2014; 6():165. PubMed ID: 25100992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
    Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
    J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.